Abundance Wealth Counselors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.03M Buy
84,415
+41,151
+95% +$1.08M 0.13% 104
2026
Q1
$1.21M Buy
43,264
+3,100
+8% +$82.5K 0.17% 87
2025
Q4
$1M Buy
40,164
+785
+2% +$19.8K 0.17% 95
2025
Q3
$1M Buy
39,379
+1,530
+4% +$37.8K 0.17% 95
2025
Q2
$917K Buy
37,849
+6,649
+21% +$155K 0.17% 96
2025
Q1
$791K Buy
31,200
+4,737
+18% +$124K 0.17% 98
2024
Q4
$702K Buy
+26,463
New +$718K 0.15% 104
2021
Q2
Sell
-1,413
Closed -$51K 267
2021
Q1
$51K Buy
+1,413
New +$50.2K 0.01% 165

Other funds holding PFE

Abundance Wealth Counselors's PFE Position: Q2 2026 in Review

Abundance Wealth Counselors increased its Pfizer (PFE) stake by 95% in Q2 2026, buying an estimated $1.08M and bringing the position to 84,415 shares worth $2.03M. The position accounts for 0.13% of the portfolio, ranked #104.

Abundance Wealth Counselors first reported a position in PFE in Q1 2021 and has held it in 8 quarters since. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Abundance Wealth Counselors held 84,415 shares of Pfizer worth $2.03M as of Q2 2026.
  • Abundance Wealth Counselors bought 41,151 Pfizer shares in Q2 2026, an estimated $1.08M.
  • Pfizer made up 0.13% of Abundance Wealth Counselors's portfolio in Q2 2026, its #104 holding.
  • Abundance Wealth Counselors first reported a position in Pfizer in Q1 2021 and has held it in 8 quarters since.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Abundance Wealth Counselors's 13F filing for Q2 2026, filed 23 Jul 2026.